BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38727779)

  • 1. Global trends in pharmacovigilance-related events: a 30-year analysis from the 2019 global burden of disease study.
    Lin S; Lei S; Liu W; Zhu X; Yin L; Liu Q; Feng B
    Int J Clin Pharm; 2024 May; ():. PubMed ID: 38727779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 DALYs and HALE Collaborators
    Lancet; 2016 Oct; 388(10053):1603-1658. PubMed ID: 27733283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global, regional, and national trends in osteoarthritis disability-adjusted life years (DALYs) from 1990 to 2019: a comprehensive analysis of the global burden of disease study.
    Ding Y; Liu X; Chen C; Yin C; Sun X
    Public Health; 2024 Jan; 226():261-272. PubMed ID: 38134839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 DALYs and HALE Collaborators
    Lancet; 2017 Sep; 390(10100):1260-1344. PubMed ID: 28919118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global trends and partial forecast of adverse effects of medical treatment from 1990 to 2019: an epidemiological analysis based on the global burden of disease study 2019.
    Kong X; Tao X; Li L; Zhao X; Ren J; Yang S; Chen X; Xiang H; Wu G; Li Y; Dong D
    BMC Public Health; 2024 Jan; 24(1):295. PubMed ID: 38273270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Risk Factor Collaborators
    Lancet; 2018 Nov; 392(10159):1923-1994. PubMed ID: 30496105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global Incidence and Mortality Trends due to Adverse Effects of Medical Treatment, 1990-2017: A Systematic Analysis from the Global Burden of Diseases, Injuries and Risk Factors Study.
    Nauman J; Soteriades ES; Hashim MJ; Govender R; Al Darmaki RS; Al Falasi RJ; Ojha SK; Masood-Husain S; Javaid SF; Khan MA
    Cureus; 2020 Mar; 12(3):e7265. PubMed ID: 32195071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global, regional and national time trends in incidence of adverse effects of medical treatment, 1990-2019: an age-period-cohort analysis from the Global Burden of Disease 2019 study.
    Lin L
    BMJ Qual Saf; 2024 Jun; ():. PubMed ID: 38862263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global, regional, and national time trends in disability-adjusted life years, mortality, and variable risk factors of non-rheumatic calcified aortic valve disease, 1990-2019: an age-period-cohort analysis of the Global Burden of Disease 2019 study.
    Liu Z; Su Z; Li W; Zhang F; Ouyang W; Wang S; Pan X
    J Thorac Dis; 2023 Apr; 15(4):2079-2097. PubMed ID: 37197484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 Mortality and Causes of Death Collaborators
    Lancet; 2016 Oct; 388(10053):1459-1544. PubMed ID: 27733281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global, regional, and national incidence, mortality, and disability-adjusted life years of non-rheumatic valvular heart disease and trend analysis from 1990 to 2019: Results from the Global Burden of Disease study 2019.
    Wang K; Geng B; Shen Q; Wang Y; Shi J; Dong N
    Asian Cardiovasc Thorac Ann; 2023 Oct; 31(8):706-722. PubMed ID: 37674443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015.
    GBD 2015 Tobacco Collaborators
    Lancet; 2017 May; 389(10082):1885-1906. PubMed ID: 28390697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019.
    Shin YH; Hwang J; Kwon R; Lee SW; Kim MS; ; Shin JI; Yon DK
    Allergy; 2023 Aug; 78(8):2232-2254. PubMed ID: 37431853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global burden of rheumatoid arthritis among adolescents and young adults aged 10-24 years: A trend analysis study from 1990 to 2019.
    Li R; Yuan X; Ou Y
    PLoS One; 2024; 19(4):e0302140. PubMed ID: 38625989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Mortality Collaborators
    Lancet; 2017 Sep; 390(10100):1084-1150. PubMed ID: 28919115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Causes of Death Collaborators
    Lancet; 2017 Sep; 390(10100):1151-1210. PubMed ID: 28919116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global Trends and Forecast of the Burden of Adverse Effects of Medical Treatment: Epidemiological Analysis Based on the Global Burden of Disease Study.
    Khan MA; Soteriades ES; King J; Govender R; Hashim MJ; Masood-Husain S; Javaid SF; Debaib Mohammed Saeed Al Darei S; Dahi Al Sheryani S; Nauman J
    Cureus; 2020 Mar; 12(3):e7250. PubMed ID: 32195068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global and national burden of atherosclerosis from 1990 to 2019: trend analysis based on the Global Burden of Disease Study 2019.
    Chen W; Li Z; Zhao Y; Chen Y; Huang R
    Chin Med J (Engl); 2023 Oct; 136(20):2442-2450. PubMed ID: 37677929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends and projections of inflammatory bowel disease at the global, regional and national levels, 1990-2050: a bayesian age-period-cohort modeling study.
    Zhou JL; Bao JC; Liao XY; Chen YJ; Wang LW; Fan YY; Xu QY; Hao LX; Li KJ; Liang MX; Hu TH; Liu ZJ; Hu YQ
    BMC Public Health; 2023 Dec; 23(1):2507. PubMed ID: 38097968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Cirrhosis Collaborators
    Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):245-266. PubMed ID: 31981519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.